Top Companies in the Philippines Autoimmune Disease Market

Q: How do companies improve treatment accessibility in the Philippines?

Dominant players like Roche and Novartis, implement Patient Access Programs, which provide financial assistance to help patients complete their biological therapy cycles.

Q: Which organization leads in the Lupus treatment in the Philippines?

GSK Philippines is the dominant leader in the treatment of Systemic Lupus Erythematosus, which provide specialized biological therapies.

Q: Are biological therapies widely available in Philippine public hospitals?

Brands like Pfizer and AbbVie are collaborating with the Department of Health to include these treatments in specialized government procurement programs.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Emerging Companies in the Philippines Autoimmune Disease Market | Key Players 2026

Code: MTA12262

Publication Date: Apr 2026

Emerging Companies in the Philippines Autoimmune Disease Market

The Philippines autoimmune disease market is distinguished by the presence of multinational pharmaceutical corporations that partner with local healthcare providers and government agencies. The key players in the market include AbbVie Philippines, Roche Philippines, Novartis Philippines, Pfizer Philippines, Johnson & Johnson (Janssen), Sanofi Philippines, Eli Lilly Philippines, Bristol Myers Squibb, GSK Philippines, and Takeda Philippines.

Philippines Autoimmune Disease Market Overview

According to 6Wresearch, the Philippines autoimmune disease market is experiencing steady expansion, driven by a growing awareness of chronic inflammatory conditions and improved diagnostic capabilities in urban centres. The market is rising due to an increase in specialized treatments for conditions such as systemic lupus erythematosus, rheumatoid arthritis, and psoriasis. Moreover, the rise of specialty infusion clinics has made advanced immunology treatments more accessible to the Filipino population.

Competitive Landscape

The competitive landscape of the Philippines autoimmune disease industry is determined by global biopharmaceutical giants who optimize local distribution networks. Industry leaders are focusing on patient adherence programs and the development of biosimilars.

Below is a list of leading players operating in the Philippines Autoimmune Disease Market:

1. AbbVie Philippines

Company Name	AbbVie Philippines
Established Year	2013 (Global spin-off)
Headquarters	North Chicago, USA (Local HQ: Taguig City, Philippines)
Official Website	Click Here

AbbVie is a dominant force in the Filipino immunology sector, providing gold-standard biological treatments for rheumatoid arthritis and ankylosing spondylitis.

2. Roche Philippines

Company Name	Roche Philippines
Established Year	1896 (Global presence)
Headquarters	Basel, Switzerland (Local HQ: Taguig City, Philippines)
Official Website	Click Here

Roche is a leader in biotechnology and diagnostics, focusing on innovative therapies for rheumatoid arthritis and maintaining a strong presence in personalized healthcare.

3. Novartis Philippines

Company Name	Novartis Philippines
Established Year	1996 (Global presence)
Headquarters	Basel, Switzerland (Local HQ: Makati City, Philippines)
Official Website	Click Here

Novartis provides a comprehensive range of immunology solutions, particularly known for its advanced treatments for dermatological spondylarthritis conditions.

4. Pfizer Philippines

Company Name	Pfizer Philippines
Established Year	1849 (Global presence)
Headquarters	New York, USA (Local HQ: Makati City, Philippines)
Official Website	Click Here

Pfizer has a long-standing history, supplying critical JAK inhibitors and various biosimilar options that cater to patients with chronic inflammatory diseases.

5. Johnson & Johnson (Janssen)

Company Name	Johnson & Johnson (Janssen)
Established Year	1886 (Parent Company)
Headquarters	New Brunswick, USA (Local HQ: Parañaque City, Philippines)
Official Website	Click Here

Janssen is a top-tier provider of immunology products, focusing heavily on gastroenterology and psoriatic arthritis.

6. Sanofi Philippines

Company Name	Sanofi Philippines
Established Year	1973 (Global presence)
Headquarters	Paris, France (Local HQ: Taguig City, Philippines)
Official Website	Click Here

Sanofi is a major player in the local specialty care market, offering advanced biological therapies for atopic dermatitis.

7. Eli Lilly Philippines

Company Name	Eli Lilly Philippines
Established Year	1876 (Global presence)
Headquarters	Indianapolis, USA (Local HQ: Makati City, Philippines)
Official Website	Click Here

Eli Lilly focuses on delivering innovative breakthroughs for the Filipino market, specifically in the areas of moderate-to-severe rheumatoid arthritis.

8. Bristol Myers Squibb

Company Name	Bristol Myers Squibb
Established Year	1887 (Global presence)
Headquarters	New Jersey, USA (Local HQ: Makati City, Philippines)
Official Website	Click Here

Bristol Myers Squibb is a key innovator, providing specialty medicines that modulate the immune system to treat various autoimmune disorders.

9. GSK Philippines

Company Name	GSK Philippines
Established Year	1715 (Global presence)
Headquarters	London, UK (Local HQ: Makati City, Philippines)
Official Website	Click Here

GSK maintains a strong footprint, particularly in the management of Systemic Lupus Erythematosus, a condition with high clinical priority.

10. Takeda Philippines

Company Name	Takeda Philippines
Established Year	1781 (Global presence)
Headquarters	Tokyo, Japan (Local HQ: Taguig City, Philippines)
Official Website	Click Here

Takeda is a significant contributor to the healthcare sector, focusing on gastroenterology and specialty immunology treatments for inflammatory bowel disease.